帝王国际投资(00928.HK)宣布,旗下附属公司安各洛合成、安各洛生物技术及深圳超氧与合营伙伴王晓凤于中国成立合资企业,分别持股34%及63%。合资企业已获各方按股权比例注入合共970万元资金,其中公司出资340万元,未来将专注发展超氧化物歧化酶(SOD)业务。公司预期,SOD技术可应用于高端医美、功能性食品及专业医疗等战略性领域,具备覆盖生产工艺的核心专利群及独家设备设计专利保护,相信可开辟新...
Source Link帝王国际投资(00928.HK)宣布,旗下附属公司安各洛合成、安各洛生物技术及深圳超氧与合营伙伴王晓凤于中国成立合资企业,分别持股34%及63%。合资企业已获各方按股权比例注入合共970万元资金,其中公司出资340万元,未来将专注发展超氧化物歧化酶(SOD)业务。公司预期,SOD技术可应用于高端医美、功能性食品及专业医疗等战略性领域,具备覆盖生产工艺的核心专利群及独家设备设计专利保护,相信可开辟新...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.